The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 13, 2014
Filed:
Jun. 01, 2011
Jorge Berlanga Acosta, Ciudad de la Habana, CU;
Danay Cibrian Vera, Ciudad de la Habana, CU;
Diana Garcia Del Barco Herrera, Ciudad de la Habana, CU;
Gerardo Enrique Guillén Nieto, Ciudad de la Habana, CU;
José Suarez Alba, Ciudad de la Habana, CU;
Ernesto Lopez Mola, Ciudad de la Habana, CU;
Manuel Selman-housein Sosa, Ciudad de la Habana, CU;
Mariela Vazquez Castillo, Ciudad de la Habana, CU;
Jorge Berlanga Acosta, Ciudad de la Habana, CU;
Danay Cibrian Vera, Ciudad de la Habana, CU;
Diana Garcia Del Barco Herrera, Ciudad de la Habana, CU;
Gerardo Enrique Guillén Nieto, Ciudad de la Habana, CU;
José Suarez Alba, Ciudad de la Habana, CU;
Ernesto Lopez Mola, Ciudad de la Habana, CU;
Manuel Selman-Housein Sosa, Ciudad de la Habana, CU;
Mariela Vazquez Castillo, Ciudad de la Habana, CU;
Centro de Ingenieria Genetica y Biotecnologia, Ciudad de la Habana, CU;
Abstract
The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma.